Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Naproxen for Dysmenorrhea and Bladder Pain Sensitivity
NCT03697720Phase 4Completed
- Sponsor
- Endeavor Health
- Start
- May 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of naproxen in dysmenorrhea, sponsored by Endeavor Health. Primary endpoints: Change in Menstrual Pain and Change in Participant Bladder Pain Sensitivity From Baseline. Started May 2018; status: completed.
02
Drugs
naproxen
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT03697720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03697720.